Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study

Genes Chromosomes and Cancer

Volumn 52, Issue 7, 2013, Pages 595-609

  Pellatt, Andrew J ^a   Wolff, Roger K ^a   Torres Mejia, Gabriela ^b   John, Esther M ^c,d   Herrick, Jennifer S ^a   Lundgreen, Abbie ^a   Baumgartner, Kathy B ^e   Giuliano, Anna R ^f   Hines, Lisa M ^g   Fejerman, Laura ^h   Cawthon, Richard ^a   Slattery, Martha L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MEIOTIC RECOMBINATION 11 HOMOLOG A PROTEIN; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 PROTEIN; PROGESTERONE RECEPTOR; PROTEIN; RECQ PROTEIN LIKE 5; TELOMERASE ASSOCIATED PROTEIN 1; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERE RNA COMPONENT; TELOMERIC REPEAT BINDING FACTOR 2; TRF1 INTERACTING ANKYRIN RELATED ADP RIBOSE POLYMERASE; TRF1 INTERACTING ANKYRIN RELATED ADP RIBOSE POLYMERASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CODON; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOMIC INSTABILITY; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84877927225     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22056     Document Type: Article

References (64)

1. Akman A, Yilmaz E, Mutlu H, Ozdogan M. 2009. Complete remission of psoriasis following bevacizumab therapy for colon cancer. Clin Exp Dermatol 34:e202-e204.
2. Bautista CV, Felis CP, Espinet JM, Garcia JB, Salas JV. 2007. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum 50:611-620.
3. Cassidy A, De Vivo I, Liu Y, Han J, Prescott J, Hunter DJ, Rimm EB. 2010. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 91:1273-1280.
4. Cawthon RM. 2009. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21.
5. Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ. 2006. Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice. Mol Cell Biol 26:2037-2043.
6. Cui Y, Cai Q, Qu S, Chow WH, Wen W, Xiang YB, Wu J, Rothman N, Yang G, Shu XO, Gao YT, Zheng W. 2012. Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the shanghai women's health study. Cancer Epidemiol Biomarkers Prev 21:1807-1813.
7. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. 2004. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101:17312-17315.
8. Falush D, Stephens M, Pritchard JK. 2003. Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164:1567-1587.
9. Friedrich U, Griese E, Schwab M, Fritz P, Thon K, Klotz U. 2000. Telomere length in different tissues of elderly patients. Mech Ageing Dev 119:89-99.
10. Gao J, Zhang J, Long Y, Tian Y, Lu X. 2011. Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity. Pathol Oncol Res 17:685-690.
11. Gelmini S, Poggesi M, Distante V, Bianchi S, Simi L, Luconi M, Raggi CC, Cataliotti L, Pazzagli M, Orlando C. 2004. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett 216:81-87.
12. Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, Zhou J, Chng WJ, Li S, Liu E, Tergaonkar V. 2012. Telomerase directly regulates NF-kappaB-dependent transcription. Nat Cell Biol 14:1270-1281.
13. Gramatges MM, Telli ML, Balise R, Ford JM. 2010. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 19:605-613.
14. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, De Vivo I. 2009. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 129:415-421.
15. Hoen PW, de Jonge P, Na BY, Farzaneh-Far R, Epel E, Lin J, Blackburn E, Whooley MA. 2011. Depression and leukocyte telomere length in patients with coronary heart disease: Data from the heart and soul study. Psychosom Med 73:541-547.
16. Hofer P, Baierl A, Feik E, Fuhrlinger G, Leeb G, Mach K, Holzmann K, Micksche M, Gsur A. 2011. MNS16A tandem repeats minisatellite of human telomerase gene: A risk factor for colorectal cancer. Carcinogenesis 32:866-871.
17. Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi S, Ishida T, Yamauchi A. 2010. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: Possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res Treat 122:395-407.
18. Islam MN, Paquet N, Fox D, Dray E, Zheng XF, Klein H, Sung P, Wang W. 2012. A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization. J Biol Chem 287; 23808-23818.
19. John EM, Horn-Ross PL, Koo J. 2003. Lifetime physical activity and breast cancer risk in a multiethnic population: The San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 12:1143-1152.
20. John EM, Phipps AI, Davis A, Koo J. 2005. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14:2905-2913.
21. Jones AM, Beggs AD, Carvajal-Carmona L, Farrington S, Tenesa A, Walker M, Howarth K, Ballereau S, Hodgson SV, Zauber A, Bertagnolli M, Midgley R, Campbell H, Kerr D, Dunlop MG, Tomlinson IP. 2012. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 61:248-254.
22. Kim S, Sandler DP, Carswell G, De Roo LA, Parks CG, Cawthon R, Weinberg CR, Taylor JA. 2011. Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: Results from the Sister Study. Cancer Causes Control 22:1061-1066.
23. Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, Hosgood HD, 3rd, Albanes D, Rothman N. 2009. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 15:7429-7433.
24. Li J, Ji L. 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:221-227.
25. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M, Wolkowitz O, Mellon S, Blackburn E. 2010. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods 352:71-80.
26. Loizidou MA, Cariolou MA, Neuhausen SL, Newbold RF, Bashiardes E, Marcou Y, Michael T, Daniel M, Kakouri E, Papadopoulos P, Malas S, Hadjisavvas A, Kyriacou K. 2010. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast Cancer Res Treat 121:147-156.
27. Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, Mitidieri M, Katsaros D, Yu H. 2011. Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res 13:R56.
28. Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ. 2009. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer. Pharmacogenet Genom 19:95-102.
29. Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD, 3rd, Shen M, Wei Q. 2011. Shortened telomere length is associated with increased risk of cancer: A meta-analysis. PLoS One 6:e20466.
30. Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A, Benitez J. 2011. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet 7:e1002182.
31. McCabe N, Cerone MA, Ohishi T, Seimiya H, Lord CJ, Ashworth A. 2009. Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene 28:1465-1470.
32. Meeker AK. 2006. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. Urol Oncol 24:122-130.
33. Meeker AK, Argani P. 2004. Telomere shortening occurs early during breast tumorigenesis: A cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia 9:285-296.
34. Miki Y. 2012. Cellular functions of BRCA genes - from basic science to therapeutics. Gan To Kagaku Ryoho 39:498-501.
35. Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB, Savage SA. 2009. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 8:405-413.
36. Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Peplonska B, Sherman ME, Savage SA. 2010a. Leukocyte telomere length in a population-based case-control study of ovarian cancer: A pilot study. Cancer Causes Control 21:77-82.
37. Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JY, Chatterjee N, Hayes RB, Savage SA. 2010b. The association of telomere length and genetic variation in telomere biology genes. Hum Mutat 31:1050-1058.
38. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, Berndt SI, Burdett L, Chowdhury S, Teshome K, Douglass C, Savage SA. 2011. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet 2:19-29.
39. Mohajeri A, Zarghami N, Pourhasan Moghadam M, Alani B, Montazeri V, Baiat A, Fekhrjou A. 2011. Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: Possible relationship to steroid hormone receptors. Oncol Res 19:375-380.
40. Mukherjee S, Firpo EJ, Wang Y, Roberts JM. 2011. Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci USA 108:E1363-E1371.
41. Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, Qureshi AA, Hunter DJ, Han J. 2011. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res 71:6758-6763.
42. Njajou OT, Hsueh WC, Blackburn EH, Newman AB, Wu SH, Li R, Simonsick EM, Harris TM, Cummings SR, Cawthon RM. 2009. Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci 64:860-864.
43. O'Donovan A, Pantell MS, Puterman E, Dhabhar FS, Blackburn EH, Yaffe K, Cawthon RM, Opresko PL, Hsueh WC, Satterfield S, Newman AB, Ayonayon HN, Rubin SM, Harris TB, Epel ES. 2011. Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study. PLoS One 6:e19687.
44. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. 2009. Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival. Clin Med Res 7:4-13.
45. Pellatt AJ, Wolff RK, Lundgreen A, Cawthon R, Slattery ML. 2012. Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study. Int J Mol Epidemiol Genet 3:184-194.
46. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM. 2010. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 70:3170-3176.
47. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959.
48. Puterman E, Lin J, Blackburn E, O'Donovan A, Adler N, Epel E. 2010. The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS One 5:e10837.
49. Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF, Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL. 2011. Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Res 71:5792-5805.
50. Salhab M, Jiang WG, Newbold RF, Mokbel K. 2008. The expression of gene transcripts of telomere-associated genes in human breast cancer: Correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 109:35-46.
51. Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M. 2007. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 97:832-836.
52. Seinost G, Renner W, Brodmann M, Winkler M, Koppel H, Pilger E. 2000. C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Thromb Res 100:405-407.
53. Sens-Abuazar C, Napolitano EFE, Osorio CA, Krepischi AC, Ricca TI, Castro NP, da Cunha IW, Maciel Mdo S, Rosenberg C, Brentani MM, Soares FA, Rocha RM, Carraro DM. 2012. Down-regulation of ANAPC13 and CLTCL1: Early events in the progression of preinvasive ductal carcinoma of the Breast. Transl Oncol 5:113-123.
54. Shammas MA. 2011. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care 14:28-34.
55. Shen J, Gammon MD, Terry MB, Bradshaw PT, Wang Q, Teitelbaum SL, Neugut AI, Santella RM. 2012. Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival. Breast Cancer Res Treat 134:393-400.
56. Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, Wolff R, Murtaugh M, Baumgartner R, Giuliano A, Byers T. 2007. Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102:85-101.
57. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, Hines LM, Stern MC, Wolff RK. 2012. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33:1512-1521.
58. Suarez MM, Bautista RM, Almela M, Soriano A, Marco F, Bosch J, Martinez JA, Bove A, Trilla A, Mensa J. 2007. Listeria monocytogenes bacteremia: Analysis of 110 episodes. Med Clin 129:218-221.
59. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G. 2008. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 68:3618-3623.
60. Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, Henriksson R, Svenson U, Tavelin B, Roos G, Hemminki K, Lenner P, Forsti A. 2009. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer 45:3008-3016.
61. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. 2011. The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1238-1250.
62. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH. 2011. Leukocyte telomere length in major depression: Correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One 6:e17837.
63. Yanowsky K, Barroso A, Osorio A, Urioste M, Benitez J, Martinez-Delgado B. 2012. Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres. Breast Cancer Res Treat 134; 1337-1343.
64. Zheng YL, Ambrosone C, Byrne C, Davis W, Nesline M, McCann SE. 2010. Telomere length in blood cells and breast cancer risk: Investigations in two case-control studies. Breast Cancer Res Treat 120:769-775.